CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily.
暂无分享,去创建一个
[1] J. Zeitlhofer,et al. Clinical significance of autoimmune thyroid disease in myasthenia gravis. , 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[2] H. Hedeland,et al. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. , 2009, Acta medica Scandinavica.
[3] J. Hodges,et al. Triple H syndrome: a novel autoimmune endocrinopathy characterized by dysfunction of the hippocampus, hair follicle, and hypothalamic-pituitary adrenal axis. , 2000, The Journal of clinical endocrinology and metabolism.
[4] L. del Viscovo,et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. , 2000, The Journal of clinical endocrinology and metabolism.
[5] J. Flier,et al. Leptin, nutrition, and reproduction: timing is everything. , 2000, The Journal of clinical endocrinology and metabolism.
[6] Gary R. Grotendorst,et al. Connective tissue growth factor mediates transforming growth factor β‐induced collagen synthesis: down‐regulation by cAMP , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Mariotti,et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: Results of a community-based study in northwestern Sardinia , 1999, Journal of endocrinological investigation.
[8] K. Polonsky,et al. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. , 1999, The Journal of clinical endocrinology and metabolism.
[9] L. Lau,et al. Activation-dependent Adhesion of Human Platelets to Cyr61 and Fisp12/Mouse Connective Tissue Growth Factor Is Mediated through Integrin αIIbβ3 * , 1999, The Journal of Biological Chemistry.
[10] Y. Itoyama,et al. Optic-spinal form of multiple sclerosis and anti-thyroid autoantibodies , 1999, Journal of Neurology.
[11] L. Lau,et al. The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.
[12] D. Brigstock. The Connective Tissue Growth Factor/cysteine- Rich 61/nephroblastoma Overexpressed (ccn) Family* , 2022 .
[13] L. Lau,et al. Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.
[14] E. Wilson,et al. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. , 1999, The Journal of clinical endocrinology and metabolism.
[15] B He,et al. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[17] D. Botstein,et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Mohan,et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. , 1998, The Journal of clinical endocrinology and metabolism.
[19] R. Coffey,et al. Identification of rCop-1, a New Member of the CCN Protein Family, as a Negative Regulator for Cell Transformation , 1998, Molecular and Cellular Biology.
[20] Gary R. Grotendorst,et al. Inhibition of TGF‐β‐stimulated CTGF gene expression and anchorage‐independent growth by cAMP identifies a CTGF‐dependent restriction point in the cell cycle , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] R. Simó,et al. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours , 1998, Clinical endocrinology.
[22] T. Remer,et al. Short-term impact of a lactovegetarian diet on adrenocortical activity and adrenal androgens. , 1998, The Journal of clinical endocrinology and metabolism.
[23] T. V. Kolesnikova,et al. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Yokota,et al. Expression of the Elm1 Gene, a Novel Gene of the CCN (Connective Tissue Growth Factor, Cyr61/Cef10, and Neuroblastoma Overexpressed Gene) Family, Suppresses In Vivo Tumor Growth and Metastasis of K-1735 Murine Melanoma Cells , 1998, The Journal of experimental medicine.
[25] B. Ambrosi,et al. Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. , 1998, European journal of endocrinology.
[26] L. Lau,et al. Adhesion of Human Umbilical Vein Endothelial Cells to the Immediate-Early Gene Product Cyr61 Is Mediated through Integrin αvβ3 * , 1998, The Journal of Biological Chemistry.
[27] R. Skoda,et al. Leptin Receptor Immunoreactivity in Chemically Defined Target Neurons of the Hypothalamus , 1998, The Journal of Neuroscience.
[28] J. Widimský,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1998, Diabetes Care.
[29] T. V. Kolesnikova,et al. Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. , 1997, Developmental biology.
[30] E. Wilson,et al. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] Gary R. Grotendorst. Connective tissue growth factor: a mediator of TGF-β action on fibroblasts , 1997 .
[32] M. Kimura,et al. Role of leptin in hypothalamic-pituitary function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Morris,et al. Effect of age on blood acid-base composition in adult humans: role of age-related renal functional decline. , 1996, The American journal of physiology.
[34] S. Nagalla,et al. Synthesis and Characterization of Insulin-like Growth Factor-binding Protein (IGFBP)-7 , 1996, The Journal of Biological Chemistry.
[35] M. Fassnacht,et al. Adrenal incidentalomas: a manifestation of the metabolic syndrome? , 1996, Endocrine research.
[36] R. Nachtigall,et al. The Use of Intravenous Immunoglobulin in Recurrent Pregnancy Loss Associated With Combined Alloimmune and Autoimmune Abnormalities , 1996, American journal of reproductive immunology.
[37] Gary R. Grotendorst,et al. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. , 1996, The Journal of investigative dermatology.
[38] H. Burger,et al. Clinical review 82: Androgens and the postmenopausal woman. , 1996, The Journal of clinical endocrinology and metabolism.
[39] M. Schlumberger,et al. Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. , 1996, European journal of cancer.
[40] M. Westphal,et al. Differential expression of novH and CTGF in human glioma cell lines , 1996, Clinical molecular pathology.
[41] L. Lau,et al. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion , 1996, Molecular and cellular biology.
[42] S. Aizawa,et al. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. , 1996, Oncogene.
[43] J. French,et al. The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.
[44] T. Remer,et al. Potential renal acid load of foods and its influence on urine pH. , 1995, Journal of the American Dietetic Association.
[45] D. Clemmons,et al. Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.
[46] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[47] M. Krempf,et al. Comparative study of the acute effects of resistant starch and dietary fibers on metabolic indexes in men. , 1994, The American journal of clinical nutrition.
[48] P. Ladenson,et al. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.
[49] P. Bork. The modular architecture of a new family of growth regulators related to connective tissue growth factor , 1993, FEBS letters.
[50] H. Adlercreutz,et al. Serum sex hormone-binding globulin, cardiovascular risk factors, and adrenal cortisol responses to dexamethasone and corticotropin. , 1993, Metabolism: clinical and experimental.
[51] Gary R. Grotendorst,et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. , 1993, Molecular biology of the cell.
[52] D. Johnston,et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. , 1992, The Journal of clinical endocrinology and metabolism.
[53] V. Joliot,et al. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.
[54] Gary R. Grotendorst,et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 , 1991, The Journal of cell biology.
[55] L. Lau,et al. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[56] M. Kaplan,et al. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. , 1990, Endocrinology and metabolism clinics of North America.
[57] E. Kaplan,et al. Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.
[58] L. Lau,et al. Expression of cyr61, a growth factor-inducible immediate-early gene , 1990, Molecular and cellular biology.
[59] R. Baxter,et al. On the nomenclature of the IGF binding proteins. , 1989, Acta endocrinologica.
[60] D. Ross,et al. Incidentally discovered adrenal masses. , 1989, American journal of surgery.
[61] G. Reaven. Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.
[62] T. Panzarella,et al. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. , 1988, International journal of radiation oncology, biology, physics.
[63] A. Goolden. THE INDICATIONS FOR ABLATING NORMAL THYROID TISSUE WITH 131I IN DIFFERENTIATED THYROID CANCER , 1985, Clinical endocrinology.
[64] B. Caillou,et al. Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma , 1985, Cancer.
[65] J. Sisson. Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] D. Linch,et al. CUSHING'S SYNDROME—KILLING DISEASE: DISCRIMINATORY VALUE OF SIGNS AND SYMPTOMS AIDING EARLY DIAGNOSIS , 1982, The Lancet.
[67] R. Urbanic,et al. Cushing's Disease—18 Years' Experience , 1981, Medicine.
[68] Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.
[69] G. Reaven,et al. Insulin and Glucose Responses to Identical Oral Glucose Tolerance Tests Performed Forty-eight Hours Apart , 1974, Diabetes.
[70] K. Kosaka,et al. Reproducibility of the Oral Glucose Tolerance Test and the Rice-Meal Test in Mild Diabetics , 1966, Diabetes.
[71] G. F. Fisher,et al. Reproducibility of the Oral Glucose Tolerance Test , 1965, Diabetes.
[72] H. Blumenthal,et al. Small adenomas of the adrenal cortex in hypertension and diabetes. , 1945, Archives of internal medicine.
[73] S. Chanock,et al. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. , 2000, The Journal of clinical endocrinology and metabolism.
[74] A. Araujo,et al. Diet and sex hormone-binding globulin. , 2000, The Journal of clinical endocrinology and metabolism.
[75] R.,et al. Androgens and the Postmenopausal Woman , 2000 .
[76] S. Plymate,et al. The insulin-like growth factor-binding protein superfamily. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[77] E. Baudin,et al. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? , 2000, The Journal of clinical endocrinology and metabolism.
[78] R. Tresserras,et al. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. , 1999, Diabetes research and clinical practice.
[79] B. Mollenhauer,et al. Hashimoto's encephalitis as a diVerential diagnosis of Creutzfeldt-Jakob disease , 1999 .
[80] M. Schlumberger,et al. THERAPEUTIC CONTROVERSY The Use of Radioactive Iodine in Patients with Papillary and Follicular Thyroid Cancer , 1998 .
[81] T. V. Kolesnikova,et al. CYR 61 , a product of a growth factor-inducible immediate early gene , promotes angiogenesis and tumor growth , 1998 .
[82] R. Steiner,et al. The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. , 1998, Endocrinology.
[83] 高野 加寿恵,et al. Molecular mechanisms to regulate the activities of insulin-like growth factors : proceedings of the 4th International Symposium on Insulin-like Growth Factors, at Tokyo International Forum, Tokyo, Japan, 21-24 October 1997 , 1998 .
[84] R. Rosenfeld,et al. Editorial: The Blind Men and the Elephant-A Parable for the Study of Insulin-Like Growth Factor Binding Proteins. , 1998, Endocrinology.
[85] Gary R. Grotendorst,et al. Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[86] Drop Sl. Report on the nomenclature of the IGF binding proteins. , 1992, The Journal of clinical endocrinology and metabolism.
[87] R. Baxter,et al. Report on the nomenclature of the IGF binding proteins. , 1992, Endocrinology.
[88] E. Mazzaferri. Treating differentiated thyroid carcinoma: where do we draw the line? , 1991, Mayo Clinic proceedings.
[89] J. Roberts,et al. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. , 1990, Neuron.
[90] S. Reiser. Metabolic effects of dietary pectins related to human health. , 1987 .
[91] M. O. Dayhoff,et al. Atlas of protein sequence and structure , 1965 .